Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas O Schrader

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|September 13, 2002
Stereodivergent synthesis of all 15-F(2) isoprostanesThomas O Schrader, Marc L Snapper
The Journal of Organic Chemistry|February 14, 2006
Synthesis of isoprostanyl phosphatidylcholine and isoprostanyl phosphatidylethanolamineManami Shizuka, Thomas O Schrader, Marc L Snapper
Bioorganic & Medicinal Chemistry Letters|January 26, 2025
Novel tertiary diarylethylamines as functionally selective agonists of the kappa opioid receptorThomas O Schrader, Kym I Lorrain, Matthew R Nelli, et al.
Organic Letters|December 6, 2012
Complementary asymmetric routes to (R)-2-(7-hydroxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetateThomas O Schrader, Benjamin R Johnson, Luis Lopez, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of PIPE-359, a Brain-Penetrant, Selective M<sub>1</sub> Receptor Antagonist with Robust Efficacy in Murine MOG-EAEThomas O Schrader, Yifeng Xiong, Ariana O Lorenzana, et al.
Journal of Medicinal Chemistry|June 29, 2026
Discovery of <b>PIPE-791</b>, A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory DisordersAustin Chen, Christopher Baccei, Jill Baccei, et al.
Bioorganic & Medicinal Chemistry Letters|November 20, 2016
Tetrahydroquinoline-based tricyclic amines as potent and selective agonists of the 5-HT<sub>2C</sub> receptorThomas O Schrader, Michelle Kasem, Albert Ren, et al.
ACS Chemical Neuroscience|January 24, 2024
Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment EfficacyThomas O Schrader, Kym I Lorrain, Didier Bagnol, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2014
Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptorDaniel J Buzard, Thomas O Schrader, Xiuwen Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2020
Discovery of a lead series of potent benzodiazepine 5-HT<sub>2C</sub> receptor agonists with high selectivity in functional and binding assaysAlbert Ren, Xiuwen Zhu, Konrad Feichtinger, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|September 13, 2002
Stereodivergent synthesis of all 15-F(2) isoprostanesThomas O Schrader, Marc L Snapper
The Journal of Organic Chemistry|February 14, 2006
Synthesis of isoprostanyl phosphatidylcholine and isoprostanyl phosphatidylethanolamineManami Shizuka, Thomas O Schrader, Marc L Snapper
Bioorganic & Medicinal Chemistry Letters|January 26, 2025
Novel tertiary diarylethylamines as functionally selective agonists of the kappa opioid receptorThomas O Schrader, Kym I Lorrain, Matthew R Nelli, et al.
Organic Letters|December 6, 2012
Complementary asymmetric routes to (R)-2-(7-hydroxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetateThomas O Schrader, Benjamin R Johnson, Luis Lopez, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of PIPE-359, a Brain-Penetrant, Selective M<sub>1</sub> Receptor Antagonist with Robust Efficacy in Murine MOG-EAEThomas O Schrader, Yifeng Xiong, Ariana O Lorenzana, et al.
Journal of Medicinal Chemistry|June 29, 2026
Discovery of <b>PIPE-791</b>, A Potent and Brain-Penetrant Lysophosphatidic Acid Receptor 1 Antagonist with Slow Tight Binding Characteristics for the Treatment of Neuroinflammatory DisordersAustin Chen, Christopher Baccei, Jill Baccei, et al.
Bioorganic & Medicinal Chemistry Letters|November 20, 2016
Tetrahydroquinoline-based tricyclic amines as potent and selective agonists of the 5-HT<sub>2C</sub> receptorThomas O Schrader, Michelle Kasem, Albert Ren, et al.
ACS Chemical Neuroscience|January 24, 2024
Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment EfficacyThomas O Schrader, Kym I Lorrain, Didier Bagnol, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2014
Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptorDaniel J Buzard, Thomas O Schrader, Xiuwen Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2020
Discovery of a lead series of potent benzodiazepine 5-HT<sub>2C</sub> receptor agonists with high selectivity in functional and binding assaysAlbert Ren, Xiuwen Zhu, Konrad Feichtinger, et al.
Pageof 2